1. OS01.5.A Neuron-specific enolase (NSE) and S100 serum levels in patients with active brain metastases from HER2-positive breast cancer treated with trastuzumab-deruxtecan (T-DXd): A biomarker analysis from the TUXEDO-1 trial. (5th September 2022) Authors: Berghoff, A S; Bartsch, R; Furtner, J; Marhold, M; Bergen, E S; Roider-Schur, S; Starzer, A M; Forstner, H; Rottenmanner, B; Dieckmann, K; Bago-Horvath, Z; Widhalm, G; Ilhan-Mutlu, A; Minichsdorfer, C; Fuereder, T; Singer, C F; Weltermann, A; Haslacher, H; Szekeres, T; Puhr, R Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗